Kiniksa Presents Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019

Ads

You May Also Like

Agility Health Reports 2017 Financial Results

HAMILTON, Ontario , May 30, 2018 (GLOBE NEWSWIRE) -- Agility Health, Inc. (TSXV:AHI) (“Agility ...

BioTelemetry, Inc. Announces FDA Approval of Its Next Generation Device, the MCOT™ Patch

MALVERN, Pa., July 26, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless ...